Page last updated: 2024-08-26

sr141716 and Diabetic Retinopathy

sr141716 has been researched along with Diabetic Retinopathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ho, TC; Makriyannis, A; Mastrodimou, N; Nikas, SP; Spyridakos, D; Thermos, K; Vemuri, K	1

Other Studies

1 other study(ies) available for sr141716 and Diabetic Retinopathy

Article	Year
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences, 2022, Dec-23, Volume: 24, Issue:1 Topics: Animals; Cannabinoids; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Streptozocin	2022

Article

Year

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.

International journal of molecular sciences, 2022, Dec-23, Volume: 24, Issue:1

Topics: Animals; Cannabinoids; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Streptozocin

2022